Hanns Lochmüller is awarded prestigious Tier 1 Canada Research Chair in neuromuscular genomics and health

We are thrilled to announce that Hanns has been awarded a Canada Research Chair (CRC) in Neuromuscular Genomics and Health. The announcement was made at a ceremony at the University of Victoria at noon today. The prestigious Tier 1 CRC awards are for outstanding researchers acknowledged by their peers as world leaders in their fields. The program aims to help chairholders achieve research excellence, improve Canada’s depth of knowledge and quality of life, strengthen the country’s international competitiveness, and train the next generation of highly skilled researchers through student supervision, teaching, and research coordination. In the same announcement CHEO Professor Kym Boycott was awarded a Tier 1 CRC in Rare Disease Precision Health.

Hanns said: “This CRC award is part of what enabled my move from Europe to Canada, and together with our recently awarded CIHR Project grant allows us to establish a really exciting research program in neuromuscular genomics and health here at the CHEO Research Institute in close partnership with the Department of Medicine of The Ottawa Hospital and the Brain and Mind Research Institute of Ottawa University. I’m delighted that Kym Boycott, a long-term friend and collaborator, has also received a Tier 1 chair at the same time: this is a clear demonstration of the strategic importance of rare disease research here in Ottawa and our leadership role will benefit not only Canadian patients but also many others around the world.”

Hanns with research associate and lab manager Sally Spendiff

Find out more

CHEO Research Institute press release

Government of Canada press release

Canada Research Chair program details

Hanns-crc

Read next...

New Publication: Congenital myasthenic syndrome with mild intellectual disability caused by a recurrent SLC25A1 variant

We were pleased to collaborate with colleagues in the UK, India, Germany, and Spain on this brief communication reporting three…

Conference Announcement: MITO2019 in Toronto 8-9th Nov

MITO2019 is the annual meeting for mitoNET and the MitoCanada Foundation and serves as the main education & networking event…

A new arrival accompanied by a new publication

The Lochmüller lab is pleased to welcome Dr. Emily O’Connor to the group in Ottawa. Emily marked her arrival in…

New Publication: Analysis of the functional capacity outcome measures for myotonic dystrophy

Being able to accurately and reliably asses functional capacity in people with myotonic dystrophy type 1 (DM1) is paramount to…

Foundation grant success for the Lochmüller Lab!

We are thrilled to announce that our Foundation Grant application on Precision Health for Neuromuscular Diseases (NMD) has been funded…

New publication: De-duplicating patient records from three independent data sources reveals the incidence of rare neuromuscular disorders in Germany

Patients with long-term, complex conditions like neuromuscular diseases may receive diagnosis, care and treatment in several different centres, each of…

New publication: Increasing phenotypic annotation improves the diagnostic rate of exome sequencing in a rare neuromuscular disorder

How can we use phenotypic descriptions to aid genetic diagnosis starting with hundreds of rare variants from next-generation sequencing results?…